相关实验视频
Updated: Jul 9, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
胰岛素输送技术是否会改变我们与食物的关系? 一个范围广泛的审查
Courtney A South1, Meryem K Talbo1, Amélie Roy-Fleming1
1School of Human Nutrition, McGill University, Montreal, Canada.
Diabetes technology & therapeutics
|November 30, 2023
概括
自动胰岛素输送系统 (AID) 对1型糖尿病患者的饮食行为和饮食模式产生影响. 虽然AID可以减少饮食困扰并改善生活质量,但它对碳水化合物计数准确性的影响需要进一步研究.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 糖尿病管理 糖尿病管理
背景情况:
- 自动胰岛素输送系统 (AID) 改善了1型糖尿病 (PwT1D) 患者的血糖控制.
- 关于AID和营养变量之间的关系的证据有限,包括饮食摄入量,饮食行为和饮食失调.
研究的目的:
- 进行对AID和营养变量现有文献的范围审查.
- 确定PwT1D中关于AID对饮食行为和饮食模式的影响的研究缺口.
主要方法:
- 在Medline (OVID) 和PubMed上对2000年1月至2023年7月期间发表的研究进行了全面的文献搜索.
- 包括的研究比较了所有年龄段的PwT1D中的AID使用与非AID使用.
- 七项研究 (4项定性研究,1项交叉研究,1项随机对照研究,1项观察研究) 符合纳入标准.
主要成果:
- 定量研究表明,AID与减少饮食困扰和改善生活质量有关,但在餐饮或零食中的碳水化合物摄入量没有显著变化.
- 定性研究表明,使用AID导致增加食物摄入频率和部分,减少家长的饮食控制,并偏爱高能量食物.
- 使用AID的PwT1D报告说,对准确的碳水化合物计数 (CC) 的担忧较小.
结论:
- 艾滋病使用似乎影响了PwT1D的饮食行为,饮食模式和CC.
- 人们认为AID可以弥补CC的不准确性,这可能会减轻食品管理的负担.
- 需要进一步的研究来确认AID是否简化了CC并增强了饮食行为,同时保持了血糖稳定性.
相关概念视频
Insulin Formulations: Types and Delivery
202
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
202
Insulin: Dosing Regimen and Adverse Effects
181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181
Insulin: Biosynthesis, Chemistry, and Preparation
388
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
388
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Glucagon-like Receptor Agonists
329
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
329
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K

